Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 7.24
+0.15 (2.12%)
Nov 3, 2025, 1:52 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 2.97 billion as of October 31, 2025. Its market cap has decreased by -55.99% in one year.
Market Cap
2.97B
Enterprise Value
2.81B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.24
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 2.97B, a decrease of -41.87%. That is a compound annual growth rate of -17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 2.97B | -46.04% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 181.96B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.99B |
| Polaris Group | 27.16B |
| Pegavision | 25.74B |